Treatment of meningeal carcinomatosis.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001812:Blood-Brain Barrier; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007278:Injections, Spinal; D007938:Leukemia / Q000188:drug therapy; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000628:therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008727:Methotrexate